378 related articles for article (PubMed ID: 16137474)
41. Progressive familial intrahepatic cholestasis: a personal perspective.
Knisely AS
Pediatr Dev Pathol; 2000; 3(2):113-25. PubMed ID: 10679031
[TBL] [Abstract][Full Text] [Related]
42. Overview of Progressive Familial Intrahepatic Cholestasis.
Hassan S; Hertel P
Clin Liver Dis; 2022 Aug; 26(3):371-390. PubMed ID: 35868680
[TBL] [Abstract][Full Text] [Related]
43. Linkage between a new splicing site mutation in the MDR3 alias ABCB4 gene and intrahepatic cholestasis of pregnancy.
Schneider G; Paus TC; Kullak-Ublick GA; Meier PJ; Wienker TF; Lang T; van de Vondel P; Sauerbruch T; Reichel C
Hepatology; 2007 Jan; 45(1):150-8. PubMed ID: 17187437
[TBL] [Abstract][Full Text] [Related]
44. ABCB4/MDR3 in health and disease - at the crossroads of biochemistry and medicine.
Prescher M; Kroll T; Schmitt L
Biol Chem; 2019 Sep; 400(10):1245-1259. PubMed ID: 30730833
[TBL] [Abstract][Full Text] [Related]
45. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R
Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
[TBL] [Abstract][Full Text] [Related]
46. The Bile Salt Export Pump: Molecular Structure, Study Models and Small-Molecule Drugs for the Treatment of Inherited BSEP Deficiencies.
Sohail MI; Dönmez-Cakil Y; Szöllősi D; Stockner T; Chiba P
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466755
[TBL] [Abstract][Full Text] [Related]
47. Progressive familial intrahepatic cholestasis. Genetic basis and treatment.
Jacquemin E
Clin Liver Dis; 2000 Nov; 4(4):753-63. PubMed ID: 11232355
[TBL] [Abstract][Full Text] [Related]
48. Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep/Abcb11) correlate with severity of cholestatic diseases.
Lam P; Pearson CL; Soroka CJ; Xu S; Mennone A; Boyer JL
Am J Physiol Cell Physiol; 2007 Nov; 293(5):C1709-16. PubMed ID: 17855769
[TBL] [Abstract][Full Text] [Related]
49. Clinical characteristics and genetic profiles of young and adult patients with cholestatic liver disease.
Huynh MT; Nguyen TT; Grison S; Lascols O; Fernandez E; Barbu V
Rev Esp Enferm Dig; 2019 Oct; 111(10):775-788. PubMed ID: 31538484
[TBL] [Abstract][Full Text] [Related]
50. Defects in myosin VB are associated with a spectrum of previously undiagnosed low γ-glutamyltransferase cholestasis.
Qiu YL; Gong JY; Feng JY; Wang RX; Han J; Liu T; Lu Y; Li LT; Zhang MH; Sheps JA; Wang NL; Yan YY; Li JQ; Chen L; Borchers CH; Sipos B; Knisely AS; Ling V; Xing QH; Wang JS
Hepatology; 2017 May; 65(5):1655-1669. PubMed ID: 28027573
[TBL] [Abstract][Full Text] [Related]
51. Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice.
Elamiri A; Perwaiz S; Tuchweber B; Yousef IM
Pharmacol Res; 2003 Nov; 48(5):467-72. PubMed ID: 12967592
[TBL] [Abstract][Full Text] [Related]
52. A progressive familial intrahepatic cholestasis type 2 mutation causes an unstable, temperature-sensitive bile salt export pump.
Plass JR; Mol O; Heegsma J; Geuken M; de Bruin J; Elling G; Müller M; Faber KN; Jansen PL
J Hepatol; 2004 Jan; 40(1):24-30. PubMed ID: 14672610
[TBL] [Abstract][Full Text] [Related]
53. ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population.
Anzivino C; Odoardi MR; Meschiari E; Baldelli E; Facchinetti F; Neri I; Ruggiero G; Zampino R; Bertolotti M; Loria P; Carulli L
Dig Liver Dis; 2013 Mar; 45(3):226-32. PubMed ID: 23022423
[TBL] [Abstract][Full Text] [Related]
54. BSEP: function and role in progressive familial intrahepatic cholestasis.
Thompson R; Strautnieks S
Semin Liver Dis; 2001 Nov; 21(4):545-50. PubMed ID: 11745042
[TBL] [Abstract][Full Text] [Related]
55. ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained.
Cai SY; Gautam S; Nguyen T; Soroka CJ; Rahner C; Boyer JL
Gastroenterology; 2009 Mar; 136(3):1060-9. PubMed ID: 19027009
[TBL] [Abstract][Full Text] [Related]
56. Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury.
Lang C; Meier Y; Stieger B; Beuers U; Lang T; Kerb R; Kullak-Ublick GA; Meier PJ; Pauli-Magnus C
Pharmacogenet Genomics; 2007 Jan; 17(1):47-60. PubMed ID: 17264802
[TBL] [Abstract][Full Text] [Related]
57. The bile salt export pump: clinical and experimental aspects of genetic and acquired cholestatic liver disease.
Lam P; Soroka CJ; Boyer JL
Semin Liver Dis; 2010 May; 30(2):125-33. PubMed ID: 20422495
[TBL] [Abstract][Full Text] [Related]
58. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
Stieger B
Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
[TBL] [Abstract][Full Text] [Related]
59. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
Stättermayer AF; Halilbasic E; Wrba F; Ferenci P; Trauner M
J Hepatol; 2020 Sep; 73(3):651-663. PubMed ID: 32376413
[TBL] [Abstract][Full Text] [Related]
60. Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis.
Gomez-Ospina N; Potter CJ; Xiao R; Manickam K; Kim MS; Kim KH; Shneider BL; Picarsic JL; Jacobson TA; Zhang J; He W; Liu P; Knisely AS; Finegold MJ; Muzny DM; Boerwinkle E; Lupski JR; Plon SE; Gibbs RA; Eng CM; Yang Y; Washington GC; Porteus MH; Berquist WE; Kambham N; Singh RJ; Xia F; Enns GM; Moore DD
Nat Commun; 2016 Feb; 7():10713. PubMed ID: 26888176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
